How effective is a hereditary cancer panel test for Lynch syndrome?

Lynch syndrome is associated with inherited changes in genes involved in correcting DNA errors. A panel examines several genes from a blood or saliva sample. A pathogenic finding may support a Lynch syndrome diagnosis and guide personalised screening and family discussions. A negative result can be reassuring, but its meaning depends on the family history and whether a known family change was tested.

Sometimes the laboratory reports a variant of uncertain significance. This does not confirm Lynch syndrome and should not by itself change medical care. Genetic counselling helps interpret the result, review relatives' histories and explain whether testing other family members could clarify the finding.

Collect information about cancers in close relatives, including the type and age at diagnosis if known. Ask about the panel's genes, limitations, privacy arrangements and how results will be shared. A counsellor can discuss the emotional and family implications before you provide a sample.

After the report arrives, review it with the ordering clinician or a genetics professional. Do not change screening, surgery or medication based on a result read in isolation. If a relevant inherited change is found, relatives may be offered targeted testing and a tailored surveillance plan.

The test itself is not an emergency. Contact your clinician if you receive a result you do not understand, if a family member is diagnosed with a related cancer, or if you develop symptoms such as persistent rectal bleeding, a new change in bowel habit, unexplained weight loss or ongoing abdominal symptoms. These symptoms need clinical assessment regardless of genetic testing.

Which genes are included? What would a positive, negative or uncertain result mean for me? Does my family history change interpretation? Who can explain the report? Should relatives consider testing? Which screening plan applies while results are pending?